title: Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption.
abstract: We studied bone biopsies from 26 patients with myelomatosis with apparently normal skeletal metabolism. Quantitative histomorphometric measurements suggested that skeletal disease was progressive despite normocalcaemia and normal urinary excretion rates of calcium and hydroxyproline. When biopsies were divided according to the involvement of marrow by plasma cells, bone resorption--as judged by the eroded surface--increased significantly the greater plasma cell burden. Osteoclasts were frequent with moderate tumour burdens, but there was no further increase in the number of osteoclasts when plasma cell infiltration increased by more than 50% of bone marrow. Contrary to expectation, the numbers of osteoblasts and bone formation rates were increased with bone biopsies with moderate tumour burden, but were markedly lower when plasma cell infiltration occupied more than 50% of bone marrow, due to a decreased functional capacity of osteoblasts. We conclude that skeletal bone disease in myeloma is commonly progressive despite apparently stable bone disease as judged by biochemical measurements. The major mechanism of bone loss in myelomatosis is increased osteoclastic resorption but decreased bone formation contributes to bone loss with heavy plasma cell burdens. Urinary excretion of calcium and hydroxyproline provide insensitive indices of bone resorption in myelomatosis.
authors: Department of Human Metabolism, University of Sheffield Medical School, United Kingdom.
authors: T
authors: T
authors: Taube
authors: M N
authors: MN
authors: Beneton
authors: E V
authors: EV
authors: McCloskey
authors: S
authors: S
authors: Rogers
authors: M
authors: M
authors: Greaves
authors: J A
authors: JA
authors: Kanis
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D001706:Biopsy; D015519:Bone Density; D001846:Bone Development; D016723:Bone Remodeling; D001862:Bone Resorption; D001842:Bone and Bones / Q000473:pathology* / Q000503:physiopathology; D002118:Calcium / Q000097:blood / Q000652:urine; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D010006:Osteoblasts / Q000473:pathology; D010010:Osteoclasts / Q000473:pathology; D010024:Osteoporosis / Q000378:metabolism* / Q000473:pathology*; D010710:Phosphates / Q000097:blood; D012016:Reference Values; D012709:Serum Albumin / Q000032:analysis
chemical_list: D010710:Phosphates; D012709:Serum Albumin; D003404:Creatinine; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D002118:Calcium